NuEyes' NuLoupes Receives FDA Approval for Enhanced Medical Visualization
NuEyes NuLoupes (Photo Credit: NuEyes Technologies Inc.)
NEWPORT BEACH, Calif., December 15, 2023 (VSNewsNetwork.com) - NuEyes, a company specializing in augmented reality smart glasses technology, has announced FDA approval for its groundbreaking product, NuLoupes. This patent-pending device, which combines advanced 3D stereoscopic technology with innovative design, is set to offer medical and dental practitioners a new level of precision and live 3D visualization.
NuLoupes introduces a significant technological shift in surgical and dental loupes, moving from traditional fixed magnification to high-resolution variable digital magnification. This change is expected to provide more versatility and a larger viewing area for users. Utilizing NuEyes' proprietary camera system, NuLoupes will offer live 3D stereoscopic imaging with minimal latency and deliver accurate depth perception, enhancing the natural viewing experience for detailed medical work.
Mark Greget, Founder and CEO of NuEyes, expressed his enthusiasm about the product's FDA approval, stating, "We are thrilled to announce the FDA approval of NuLoupes, a testament to our commitment to innovation and excellence in the medical technology field. NuLoupes represents a huge leap forward in visualization technology, and we are confident that they will revolutionize the way medical professionals approach their work."
In addition to the product itself, NuEyes plans to offer a limited amount of NuLoupes developer kits. These kits are targeted towards software developers, clinicians developing medical applications, or early adopters. The developer kit will include an SDK, providing access to the NuLoupes 3D stereoscopic camera sensors, IR sensor, IMU, Android operating system, Unity plug-ins, and other features. The anticipated shipping date for the developer kits is the first quarter of 2024.
NuEyes, founded in January 2016 and based in Orange County, California, initially focused on assisting individuals with eye conditions such as macular degeneration, glaucoma, and retinitis pigmentosa. Over the years, the company has expanded its market presence, catering to various augmented reality applications, including in the medical, dental, and accessibility sectors.
For more details on NuLoupes and NuEyes' other products, visit www.nueyes.com.
Source: NuEyes Technologies Inc. via Newswire
